未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 分享 收藏 分享 收藏 Exploratory analysis of biomarkers associated with clinical outcomes from the study of lenvatinib in differentiated cancer of the thyroid
Tahara, Makoto; Schlumberger, Martin; Elisei, Rossella; Habra, Mouhammed Amir; Kiyota, Naomi; Paschke, Ralf; Dutcus, Corina E.; Hihara, Taro; McGrath, Shannon; Matijevic, Mark; Kadowaki, Tadashi; Funahashi, Yasuhiro; Sherman, Steven I. 分享 收藏 Correlative analyses of serum biomarkers and clinical outcomes in the phase 2 study of lenvatinib, everolimus, and the combination, in patients with metastatic renal cell carcinoma following 1 VEGF-targeted therapyGlen, H.; Hsieh, J.; Michaelson, M. D.; Kim, H. J.; Sachdev, P.; Kadowaki, T.; Funahashi, Y.; Larkin, J.; Motzer, R. 分享 收藏 Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin LymphomaKnutson, Sarah K.; Kawano, Satoshi; Minoshima, Yukinori; Warholic, Natalie M.; Huang, Kuan-Chun; Xiao, Yonghong; Kadowaki, Tadashi; Uesugi, Mai; Kuznetsov, Galina; Kumar, Namita; Wigle, Tim J.; Klaus, Christine R.; Allain, Christina J.; Raimondi, Alejandra; Waters, Nigel J.; Smith, Jesse J.; Porter-Scott, Margaret; Chesworth, Richard; Moyer, Mikel P.; Copeland, Robert A.; Richon, Victoria M.; Uenaka, Toshimitsu; Pollock, Roy M.; Kuntz, Kevin W.; Yokoi, Akira; Keilhack, Heike 分享 收藏 Data-driven computational modeling to identify biomarkers of response to lenvatinib (E7080) in melanomaKadowaki, Tadashi; Funahashi, Yasuhiro; Matsui, Junji; Pavan, Kumar; Sachdev, Pallavi; O'Brien, Jim; Xing, Heming; McDonagh, Paul D.; Khalil, Iya; Kurzrock, Razelle; Hong, David S.; Nemunaitis, John 分享 收藏 Biological validation that SF3b is a target of the antitumor macrolide pladienolideYokoi, Akira; Kotake, Yoshihiko; Takahashi, Kentaro; Kadowaki, Tadashi; Matsumoto, Yoshiko; Minoshima, Yukinori; Sugi, Naoko H.; Sagane, Koji; Hamaguchi, Makoto; Iwata, Masao; Mizui, Yoshiharu 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Identification of endocrine disruptor biodegradation by integration of structure-activity relationship with pathway analysisKadowaki, Tadashi; Wheelock, Craig E.; Adachi, Tetsuya; Kudo, Taku; Okamoto, Shinobu; Tanaka, Nobuya; Tonomura, Koichiro; Tsujimoto, Gozoh; Mamitsuka, Hiroshi; Goto, Susumu; Kanehisa, Minoru 分享 收藏 Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisationKawanishi, H.; Takahashi, T.; Ito, M.; Matsui, Y.; Watanabe, J.; Ito, N.; Kamoto, T.; Kadowaki, T.; Tsujimoto, G.; Imoto, I.; Inazawa, J.; Nishiyama, H.; Ogawa, O. 分享 收藏 Inhibition of protein kinase CK2 prevents the progression of glomerulonephritisYamada, M; Katsuma, S; Adachi, T; Hirasawa, A; Shiojima, S; Kadowaki, T; Okuno, Y; Koshimizu, TA; Fujii, S; Sekiya, Y; Miyamoto, Y; Tamura, M; Yumura, W; Nihei, H; Kobayashi, M; Tsujimoto, G 分享 收藏 Hypertention in the elderly: Analyses on NIPPON DATA80, 1980-94Nakamura, Y; Tamaki, S; Okamura, T; Kadowaki, T; Hayakawa, T; Kita, Y; Kanda, H; Okayama, A; Ueshima, H 分享 收藏 Gene expression profile in experimental mesangial proliferative glomerulonephritisIzumi, Y; Izumiya, Y; Shiota, M; Yukimura, T; Shiojima, S; Yamada, M; Kadowaki, T; Katsuma, S; Hirasawa, A; Tsujimoto, G; Iwao, H 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
